This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Galectin (LGALS9), N-His-SUMO
Product Overview
BioVenic's Recombinant Canine Galectin (LGALS9), N-His-SUMO is a recombinant protein expressed from E.coli. Its predicted molecular weight is 51.7 kDa. The purity is> 90%.
Specifications
Target Information
Canine Galectin (LGALS9) is a member of the galectin family, involved in immune regulation and cell signaling. It is expressed in various immune cells, including lymphocytes and dendritic cells, and plays a role in modulating immune responses. LGALS9 can induce the proliferation and activation of immune cells while also promoting apoptosis, influencing the balance of immune cell populations. In canine tumors, LGALS9 is ubiquitously expressed, suggesting its involvement in tumor immunology. Additionally, LGALS9 is critical for mucosal adaptive immunity through the T helper 17-IgA axis, highlighting its importance in mucosal defense mechanisms.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -80°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10 mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimize freeze-thaw cycles.